bibliographic entry 7194726 [be/7194726]
https://w3id.org/oc/corpus/be/7194726

is a

• bibliographic reference

content

• Motzer, RJ, Escudier, B, Tomczak, P, Hutson, TE, Michaelson, MD, Negrier, S, Oudard, S, Gore, ME, Tarazi, J, Hariharan, S, Chen, C, Rosbrook, B, Kim, S, Rini, BI. Axitinib versus sorafenib as second-line treatment for advanced renal cell carcinoma: overall survival analysis and updated results from a randomised phase 3 trial, Lancet Oncol, 2013, 14, 6, 552, 562, PMID: 23598172

references

• https://w3id.org/oc/corpus/br/275924